# Checkpoint AR: AQ PAF Diagnostic Artifact Review

## Objective

Review the Checkpoint AQ `GOLD#` H1 PAF diagnostic artifacts without rerunning MT5 and decide the next safe research step.

## Scope

In scope:

- Read AQ artifact summaries.
- Review execution safety.
- Review diagnostic classification distribution.
- Review regime and spread distribution.
- Decide whether PAF is ready for implementation or only shadow-outcome specification.

Out of scope:

- MT5 execution.
- Strategy Tester execution.
- EA/source changes.
- Preset changes.
- Script/tool changes.
- Optimization.
- Market orders.
- Pending orders.
- Position modification.
- Profitability interpretation.

## Result

RunId: `run_20260707_151857`

| Window | Execution | Report | Trades | Diagnostics | Forbidden | Fallback |
|---|---|---|---:|---:|---:|---:|
| AQ-W1 | PASS | FOUND | 0 | 386 | 0 | 0 |
| AQ-W2 | PASS | FOUND | 0 | 267 | 0 | 0 |
| AQ-W3 | PASS | FOUND | 0 | 301 | 0 | 0 |

## Interpretation

The diagnostic workflow passed. The artifact review does not justify order implementation yet.

PAF labels are present across all three windows, but they still need shadow-outcome labeling before any entry or pending-order implementation.

AQ-W3 has materially higher spread, so spread attribution is required before using AQ-W3 as strategy-quality evidence.

## Classification

```text
PAF_DIAGNOSTIC_WORKFLOW_PASS
SHADOW_OUTCOME_SPEC_READY
NOT_READY_FOR_ORDER_IMPLEMENTATION
```

## Recommended Next Step

Checkpoint AS: PAF Shadow Outcome Labeling Specification.

This should remain no-order and no-optimization. It should define how to evaluate possible PAF labels against hypothetical outcomes without placing orders.
